Evidence map›Paper›PMID 36140031›Full record

ArticleAntibiotics (Basel, Switzerland)2022

First Belgian Report of Ertapenem Resistance in an ST11

Hanne Debergh, Margo Maex, Cristina Garcia-Graells, Cécile Boland, Marc Saulmont, Koenraad Van Hoorde, Claude Saegerman

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Microorganisms · 2026
    Review
  2. Review
  3. Article
  4. Molecular epidemiology ofAntimicrobial agents and chemotherapy · 2025
    Article
  5. A Retrospective Analysis ofMicroorganisms · 2024
    Article
  6. Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2023
    Article
  7. Beta-Lactam Antibiotic Resistance Genes in the Microbiome of the Public Transport System of Quito, Ecuador.International journal of environmental research and public health · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hanne DeberghService Foodborne Pathogens, Sciensano, B-1050 Brussels, Belgium.ORCID 0000-0002-3600-1000
Margo MaexService Bacterial Diseases, Sciensano, B-1050 Brussels, Belgium.
Cristina Garcia-GraellsService Foodborne Pathogens, Sciensano, B-1050 Brussels, Belgium.
Cécile BolandVeterinary Bacteriology Service, Sciensano, B-1050 Brussels, Belgium.ORCID 0000-0001-5610-2127
Marc SaulmontAssociation Régionale de Santé et d'Identification Animales, B-5590 Ciney, Belgium.
Koenraad Van HoordeService Foodborne Pathogens, Sciensano, B-1050 Brussels, Belgium.
Claude SaegermanResearch Unit in Epidemiology and Risk Analysis Applied to Veterinary Sciences (UREAR-ULiège), Fundamental and Applied Research for Animal and Health (FARAH) Center, University of Liège, B-4000 Liège, Belgium.ORCID 0000-0001-9087-7436
Sciensano (Belgium) · BEUniversity of Liège · BE

Funding

Sciensano (Belgium) Grant from Sciensano for the Missing-Link project : "Investigation of resistance mechanisms in emerging pathogens with the 'One Health' concept as missing link
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial resistance (AMR)carbapenemcompanion animalemerging riskhybrid sequencingKlebsiella pneumoniaeOmpK37sepsissequence type 11

Identifiers

PMID36140031
PMCPMC9495147
OpenAlexW4296096938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.